###### Strengths and limitations of this study

-   Identification of the individual factors which may influence patients' behaviours when they are considering undergoing cytological testing at primary healthcare (PHC) office.

-   Joining the patients' answers with the characteristics of their physicians.

-   Study conducted in randomly selected PHC offices (minimal sample size reached in both the physician and patient groups).

-   The percentage of women who would be willing to receive pap smears at their general practitioner office is high, which is valuable information from a cost-allocation perspective.

-   Results are not fully representative of the whole Polish population (the survey only being conducted in one region).

Introduction {#s1}
============

The WHO estimates that about 266 000 women die of cervical cancer annually, making this one of the leading causes of cancer death in the world. Despite the high mortality rate, cervical cancer is a largely preventable disease. Human papillomavirus (HPV) is one of the most common sexually transmitted infections worldwide, and is noted as a necessary cause of cervical cancer development.[@R1] In particular, high risk HPV subtypes 16 and 18 are commonly found to be present in cervical tumours.[@R3]

It is estimated that approximately 70% of cases of cervical cancer around the globe are associated with HPV types 16 and 18.[@R7] Active immunisation against these subtypes has shown to decrease the prevalence of HPV[@R8] and the incidence of cervical malignancies.[@R9] In addition to immunisation, routine Papanicolau testing (pap smear) is an effective screening tool that allows for early detection of cervical cancer. Studies have shown that cytological screening decreases the incidence[@R10] and mortality rate of cervical cancer.[@R11]

According to statistics collected in 2012 by Institut Catala d'Oncologia HPV Centre, over 1800 deaths occur every year as a result of cervical cancer in Poland, making it the second leading cause of cancer death in women. There is a national screening programme done by National Health Service Fund's which relies on sending invitations by post to encourage patients to perform regular pap smears. Despite that, the pap smear screening rate in Poland is a shockingly low 20.2%, as compared with a 70%--80% screening rate in other European Union (EU) countries.[@R16] In an effort to increase screening rates, pap smears are generally performed by primary healthcare (PHC) physicians in many countries all over the world such as Canada, Germany, Spain and Portugal, which greatly differs from Poland where pap smears are performed almost exclusively by gynaecologists.[@R17]

In addition, Poland is one of the few countries in the EU that does not currently have an HPV vaccination programme for target populations.[@R16] In order to develop strategies that can efficiently accomplish cervical cancer prevention, it is essential to obtain a thorough understanding of the determinants contributing to the low screening rate in Poland. Implementing pap smears in PHC offices may be one of the solutions to increase the effectiveness of cervical cancer screening in Poland.

Our study aims to answer the following questions:

1.  What is the PHC patient's experience with pap smear testing?

2.  What is the level of the PHC patient's willingness to undergo screening at PHC offices?

3.  Are there any associations between the professional characteristics of PHC physicians and their patients which could influence the readiness for cytological screening in a PHC setting?

Material and methods {#s2}
====================

Study design {#s2-1}
------------

A cross-sectional questionnaire-based study was conducted from January to December 2017 in Malopolska region (Krakow and surrounding small towns and villages). The data were collected by medical students and physicians, who had all received appropriate training and instructions regarding the study protocol. All patients were surveyed after their visit to their family physician (FP), while all physicians completed their surveys at the end of the consultation session.

### Sampling {#s2-1-1}

The sample size was calculated using OpenEpi software. The sample size formula n=\[(DEFF×Np(1 p)\]/\[(d2/Z21−α/2×(N−1)+p×(1 p)\] was used to calculate the number of patients and physicians needed for this study. For the patient sample (population size n=1 000 000 female inhabitants of Malopolska region aged 18--55, anticipated % frequency of patients willing to undergo pap smear in a FP office population based on pilot study results p=36%, absolute error or precision d=5%, design effect (DEFF)=1.0, significance level α=5%, Z1−α/2=1.96), the minimum patient sample size (n) was estimated to be 354. The minimum physician sample size was calculated to be 41 (n=702 primary care practices registered in Malopolska region, p=87%, d=10%, DEFF=1.0, α=5%, Z1−α/2=1.96). As in survey research, physicians are recognised as a professional group from which it is difficult to obtain high responses, therefore, a sample size of 200 physicians was chosen. To avoid bias related to practices selection random sampling by means of random-number table was used. To draw the sample, we used a local register of PHC physicians provided by the National Health Service Fund.

Patient and public involvement {#s2-2}
------------------------------

The purpose of the study was thoroughly explained to all participants. The study was conducted according to Guideline for Good Clinical Practice rules. The authors enforced the highest ethical standards for this study. The authors made sure that high standards were implemented in: comprehensive documentation for the study protocol, record keeping, training of field workers, and facilities, including computers and software. Phone inquiries were made to the managers of the selected practices to ask for their permission to conduct the study in their practice. After receiving written consent from them, one physician from each of these practices was asked for their willingness to participate in this study. On a set date, the fieldworker visited the participating PHC practice, obtained written consent from the PHC physician and handed her/him the questionnaire. Then, in the waiting-hall, the fieldworker consecutively invited the first 10 eligible patients who were visiting the selected PHC for various reasons to participate in the study. Women aged 18--55 years, with the ability to give informed consent were eligible to take part in the study.

In order to link individual participants with their responses we assigned each participant a study ID prior to collecting data. Each participant's name along with their unique study ID (eg, 001) were entered into a separate document. While collecting the data we entered each participant's unique study ID into their data document. To protect confidentiality, we used study codes on completed questionnaires and kept a separate document that linked the study code to subjects' identifying information locked in a separate location with restricted access to this document.

For the purpose of the study, two questionnaires were designed by the study team: one for patients and one for PHC physicians. The initial questionnaires were prepared based on information acquired from the review of international literature. We did not find similar studies so all the questionnaires' elements were designed by the authors after taking into consideration the aims of the research project. Both initially prepared questionnaires were then validated in a pilot study. There were 127 patients and 33 doctors in the pilot study who evaluated the face validity. The comments of the participants in the pilot study were directed at providing clarification of questions or adding more open questions. On the basis of both doctors and patients comments the final version of the questionnaire was developed. We used Cronbach's alpha to see if the multiple-item Likert scale questions were reliable. For each set of Likert scale questions, we achieved acceptable reliability (Cronbach's alpha \>0.6).

After data analysis the posters explaining the results and conclusions were displayed in all practices where the study was conducted.

### Research tool {#s2-2-1}

Finally, the patient questionnaire consisted of 25 questions, including four multiple-item Likert scale and nine semi-open questions (see [online supplementary file](#SP1){ref-type="supplementary-material"}). The rest of the questions were multiple choice questions with the possibility to choose one or more predefined answers. The first set of questions was related to sociodemographic measures and the respondents' profile (number of pregnancies and children, gender of their FP, sexual activity). This part also involved questions regarding the patient's family medical history, specifically concerning female reproductive organ cancers. The next section integrated questions concerning the individuals' knowledge about cervical cancer and their attitude towards pap smears (how often do they undergo this examination, where, reasons for not doing this regularly). The last part of the questionnaire included a patient behavioural assessment which included questions regarding whether or not the patients wish to have the possibility of undergoing cervical cancer screening in their PHC office and why or why not.
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The physicians' questionnaire data were gathered concerning the physicians' sex, age, location of the practice, number of patients seen at the practice per week, medical specialty and number of years in practice.

### Statistical analysis {#s2-2-2}

Statistical analysis was conducted using Statistica V.13.1 software. To present the results we used descriptive statistics. To investigate the associations between the attitude towards pap smears in a PHC setting and patients' and their doctors' characteristics, the χ^2^ test was used for qualitative variables and the Mann-Whitney U test was used for quantitative variables. Multivariate logistic regression analysis was used to measure for final associations between patients' characteristics and the willingness for screening in PHC adjusted for covariates.

There were few missing data in the questionnaires in different variables, although none of this was exceeding the 10% of all responses and therefore this was omitted in the final analysis. An alpha level of p=0.05 was considered as statistically significant.

Results {#s3}
=======

Respondents' characteristics {#s3-1}
----------------------------

We reached 200 physicians in their PHC centres. Finally, 43 physicians agreed to participate in the study (response rate 21.5%). Of all doctors participating---24 were women (56%). The mean age of physicians was 39.5 years (±SD 9.25). The physicians' characteristics together with the dimension of their patients' features, depending on their willingness to undergo a pap smear in their practice are shown in [table 1](#T1){ref-type="table"}.

###### 

PHC physicians' characteristics and their patients' willingness to undergo pap smear screening at their PHC office

  PHC physicians' characteristics      Patients willing to undergo screening at his/her PHC office N (%)   Patients not willing to undergo screening at his/her PHC office N (%)   P value
  ------------------------------------ ------------------------------------------------------------------- ----------------------------------------------------------------------- ------------------
  Gender                                                                                                                                                                           
   Female                              162 (64.80)                                                         66 (51.16)                                                              **p=** **0.010**
   Male                                88 (35.20)                                                          63 (48.84)                                                              
  Medical specialty: family medicine                                                                                                                                               
   Yes                                 232 (95.47)                                                         103 (88.03)                                                             **p=** **0.009**
   No                                  11 (4.53)                                                           14 (11.93)                                                              
  Population of patients                                                                                                                                                           
   Adults and children                 173 (71.19)                                                         87 (74.36)                                                              p=0.530
   Adults                              70 (28.81)                                                          30 (25.64)                                                              
  Years of experience in PHC                                                                                                                                                       
   Less than 5                         78 (32.10)                                                          31 (26.50)                                                              p=0.362
   5--15 years                         84 (34.57)                                                          49 (41.88)                                                              
   More than 15                        81 (33.33)                                                          37 (31.62)                                                              

PHC, primary healthcare.

Of 430 eligible patients, 418 consented to participate (response rate 97.2%). The mean age of the patients was 39.1 years (±SD 10.68). The patient's age did not have an influence on attitude towards cervical screening. [Table 2](#T2){ref-type="table"} presents patients' characteristics.

###### 

Patients' characteristics and their willingness to undergo pap smear screening at their PHC office

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Patients' characteristics                      Willing to undergo screening at PHC office\   Not willing to undergo screening at PHC office\   P value
                                                 N (%)                                         N (%)                                             
  ---------------------------------------------- --------------------------------------------- ------------------------------------------------- -------------------
  Place of living                                                                                                                                

   Village                                       69 (28.05)                                    62 (48.06)                                        **p\<** **0.001**

   Town \<25 000                                 11 (4.47)                                     6 (4.65)                                          

   Town 25 000--100 000                          28 (11.38)                                    18 (13.95)                                        

   City \>100 000                                138 (56.10)                                   43 (33.33)                                        

  Education                                                                                                                                      

   Less than high school                         7 (27.78)                                     6 (4.51)                                          p=0.256

   High school equivalent                        103 (40.87)                                   63 (47.37)                                        

   University education                          142 (56.35)                                   64 (48.12)                                        

  Marital status                                                                                                                                 

   Single                                        72 (30.13)                                    21 (16.67)                                        **p=** **0.030**

   Married                                       151 (63.18)                                   91 (72.22)                                        

   Divorced                                      13 (5.44)                                     12 (9.52)                                         

   Widowed                                       3 (1.26)                                      2 (1.59)                                          

  Sexual activity                                                                                                                                

   Yes                                           206 (80.78)                                   105 (79.55)                                       p=0.771

   No                                            49 (19.22)                                    27 (20.45)                                        

  Family history of female reproductive cancer                                                                                                   

   Yes                                           65 (26.10)                                    27 (20.76)                                        p=0.250

   No                                            184 (73.90)                                   103 (79.24)                                       

  Type of gynaecological visits                                                                                                                  

   Private practice                              114 (44.88)                                   55 (41.35)                                        p=0.846

   Private and public practice                   11 (4.33)                                     8 (6.02)                                          

   Public practice                               99 (38.98)                                    54 (40.60)                                        

   None                                          16 (6.30)                                     30 (22.56)                                        

  Vaccination against HPV                                                                                                                        

   Yes                                           12 (4.78)                                     7 (5.38)                                          p=0.797

   No                                            239 (95.22)                                   123 (94.62)                                       

  Pap smear ever done                                                                                                                            

   Yes                                           235 (92.16)                                   126 (96.18)                                       p=0.1

   No                                            20 (7.84)                                     5 (3.82)                                          
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------

HPV, human papillomavirus; PHC, primary healthcare.

Patients' pap smear experience and values {#s3-2}
-----------------------------------------

The majority of patients surveyed (94%) indicated that they have had at least one pap smear performed at some time in the past. Less than a half (46%) declared their last pap smear was within the last 12 months, 34% indicated their last pap smear was 1--3 years ago and for 20% it was over 3 years ago. About 49% of study participants reported getting a pap smear regularly every 3 years, 32% of getting it once per year, 9% every 5 years and 10% less than every 5 years. Half of the studied patients paid privately for a pap smear. Only 8% of females received and responded to the National Health Service Fund's invitation to get pap smear testing financed by the government. Only 5% of respondents were vaccinated against HPV.

The most frequent reason (48%) for not getting pap smears given by patients was not having any worrying symptoms, and therefore, they did not feel the need to get a pap smear. The other answers justifying non-adherence were as follows: lack of time (39%), young age (32%), embarrassment (16%), fear of bad results (12%).

Two-thirds of study participants declared a willingness to undergo free pap smear screening by their PHC physicians. In this group, most patients (64%) agreed that by visiting a PHC office frequently, there will be no need to sacrifice additional time for pap smears at a specialist's office.

[Figure 1](#F1){ref-type="fig"} presents patients' motivations behind wanting to have their pap smear testing performed in their PHC office.

![Patients'reasons for undergoing free pap smear by their PHC physician. PHC, primary healthcare.](bmjopen-2019-031317f01){#F1}

Among those objecting to receiving pap smears from PHC physicians (34%), specialist care provided by gynaecologists in case of adverse results was the main concern (83% of unwilling patients).

[Figure 2](#F2){ref-type="fig"} presents patients' reasons against undergoing free pap smear by their PHC physician.

![Patients'reasons against undergoing free pap smear by their primary healthcare physician.](bmjopen-2019-031317f02){#F2}

Factors affecting willingness to undergo pap smear in a PHC office {#s3-3}
------------------------------------------------------------------

Detailed information about the associations between patients' characteristics and the willingness to undergo screening at a PHC office is shown in [table 2](#T2){ref-type="table"}. Patients' features related with significantly higher will to undergo pap smear testing in a PHC setting were living in big cities and being single. Further analysis of the data hasn't shown a correlation between patients' age and the willingness to undergo pap smear in a PHC office (p=0.129). The results of the multivariate analysis are shown in [table 3](#T3){ref-type="table"}. Patients living in cities with population greater than 100 000 citizens were more willing to undergo pap smear in PHC than village inhabitants (OR=2.76; p\<0.001). Regarding marital status, both married and divorced patients were less likely to agree for testing by PHC physicians than single patients (OR=0.51; p=0.035 and OR=0.33; p=0.034, respectively).

###### 

Logistic regression model: willingness to undergo screening in primary healthcare as associated with patients' characteristics (OR estimates and 95% CIs of or estimates, reference group indicated in italics)

  ----------------------------------------------------------------------------------------------------
  Patients' characteristics                      OR                       Lower CI   Upper CI   
  ---------------------------------------------- ------------------------ ---------- ---------- ------
  Place of living                                                                               

  *Village*\                                     Town \<25 000            1.32       0.44       3.95
   \                                                                                            
                                                                                                

  Town 25 000--100 000                           1.46                     0.70       3.07       

  City \>100 000                                 2.76                     1.59       4.79       

  Education                                                                                     

  *Less than high school*\                       High school equivalent   0.55       0.15       2.04
                                                                                                

  University education                           0.59                     0.16       2.26       

  Marital status                                                                                

  *Single*\                                      Married                  0.51       0.27       0.95
   \                                                                                            
                                                                                                

  Divorced                                       0.33                     0.12       0.93       

  Widowed                                        0.76                     0.10       5.64       

  Sexual activity                                                                               

   *No*                                          Yes                      0.59       0.30       1.18

  Family history of female reproductive cancer                                                  

   *No*                                          Yes                      0.75       0.43       1.30

  Type of gynaecological visits                                                                 

   *None*\                                       Private practice         0.91       0.41       2.02
   \                                                                                            
                                                                                                

  Private and public practice                    0.76                     0.35       1.66       

  Public practice                                0.60                     0.18       2.01       

  Vaccination against HPV                                                                       

   *No*                                          Yes                      1.68       0.57       4.92

  Pap smear ever done                                                                           

   *No*                                          Yes                      1.49       0.47       4.53

  Age                                                                                           

                                                                          0.86       0.25       3.01
  ----------------------------------------------------------------------------------------------------

HPV, human papillomavirus.

[Table 1](#T1){ref-type="table"} presents associations between PHC physicians' characteristics and their patients' willingness to undergo pap smear screening at their PHC office. Our study revealed that the gender and specialty training in family medicine of the PHC doctor are also factors that have a positive influence on the patients' attitude in this matter. In fact, patients of female doctors were significantly more willing to have pap smears in their PHC office than patients whose doctor was male (p=0.010).

Physicians' age and workload featured by number of patient visits per week were not determining factors.

Discussion {#s4}
==========

Summary and interpretation of results {#s4-1}
-------------------------------------

Our findings provide a clearer picture of what factors influence cervical cancer screening rates. The study revealed that a majority of surveyed patients were willing to undergo pap smear screening at their PHC office. The reasoning behind this was that they do not need to seek a gynaecologist, will have shorter waiting times, their FP is more easily accessible and saving time for screening.

However, those who were unwilling were mostly concerned with possible lack of access to direct gynaecological consultation in case of abnormal or uncertain results.

This intersection of both patient and physician characteristics gives some insight into how the patient--doctor relationship is crucial in maintaining adherence to screening regimes. We found that female FP were more likely to have patients well-disposed to undergoing pap smears in the PHC setting. A likely reason for this is a greater level of comfort for the patient to have gynaecological procedures performed by a physician of the same sex.

The only physician characteristic to significantly impact patient openness to screening in the PHC setting was a specialisation in family medicine (according to the current law in Poland, the PHC doctors can be specialists in family medicine, paediatrics or internal medicine).

This could be accounted for by the unique characteristics that set FPs apart from other specialties---longer, deeper patient relationships, a greater focus on patient education, greater comfort with screening and perhaps the greater emphasis placed on women's health in family medicine practice than in internal medicine or another specialisation. It is important to note that neither the age of the doctor nor the size of the patient load were correlated with patient disposition toward screening; and similarly, among patients neither age nor education were found to be significant.

Of the patient characteristics studied, it was found that marital status (being single) and area of residence (living in a city) where significantly correlated with willingness to undergo pap smears in the PHC setting. Considering that age is not a confounding factor, the significance of marital status could be explained as an increased awareness in single women of sexually transmitted diseases and so a tendency to view screening as important and routine; if single women are more likely to see the utility of a pap smear, they would also be more likely to have it done in a PHC setting where it is more easily accessible.

The fact that living in a city is significant on the other hand, speaks quite clearly to cultural differences between urban and rural centres in the attitude toward screening, personal modesty, what the traditional roles of doctors should be and different levels of exposure to medical practice.

Strengths and limitations of the study {#s4-2}
--------------------------------------

Gathered data allowed for an examination of the individual factors which may influence patients' behaviours when they are considering undergoing cytological testing at their PHC office. The strength of the study was also the possibility of joining the patients' answers with the characteristics of their physicians.

Additionally, the study was conducted in randomly selected PHC offices, with the minimal sample size reached in both: physician and patient groups, and included participants from urban, suburban and rural communities. The study was performed anonymously so we may suspect that respondents answered the questions truthfully.

Nevertheless, the study also had some limitations. The results are not fully representative of the whole Polish population due to the survey only being conducted in one, however, large region. So, there is no reason to believe that in other regions the situation might be better. Moreover, only patients who visited their PHC physician were questioned. We may suspect that there is a number of patients who are not visiting their PHC office and that some of them receive pap smears at their gynaecologists' offices while the rest are not regularly seeking medical care at all.

Even though the estimation of the percentage of women who regularly perform the pap smears was not the primary focus of our study, we noted that received results showed a higher percentage of women who declare receiving regular pap smears compared with national statistics. This may be due to the fact that not all pap smears done by private gynaecologists are recorded in the general Polish data base, and that we need to approach the national data with caution.

On the other hand, it is also possible that the study participants provided responses which are more socially desirable, even when answering anonymously, thereby inflating the number of women receiving screening. This might be due to the fact that numerous public campaigns are trying to encourage women to perform regular pap smears. Moreover, we received answers from women who might be more concerned about their health as they visit their FPs, in comparison to other potential patients who don't.

Nonetheless, the percentage of women who would be willing to receive pap smears at their general practitioner (GP) office is high, which is valuable information from a cost-allocation perspective. Also, the studied group are patients whose attitudes towards pap smears may be potentially influenced by their physicians, therefore the population is congruent with the purpose of the study.

Comparison with other studies {#s4-3}
-----------------------------

Our findings were in line with a study performed by Favre *et al* in 2018 in France, a nation where similarly GPs often do not perform pap smears.[@R19] In their study, the participation rate in cervical cancer screening was slightly higher when a PHC physician performed smears and when the physician was female. The study assessing patient and physician factors influencing participation in cervical cancer screening in Norway revealed that higher non-adherence rates were associated with having a male PHC physician, which is in line with our findings.[@R20] An interesting finding of a recent study in Serbia was that women who regularly received pap smears showed more neutral when choosing a gynaecologist, unlike the less adherent groups that preferred a female physician.[@R21] This suggests that with cervical cancer screening becoming more widespread, the barrier to have the test performed by a male PHC physician may lessen. This study also revealed that women irregularly or never received a pap smear mainly because of lack of knowledge about pap smears, difficult access to healthcare facilities, lack of time, discomfort and anxiety of pap smear results.[@R21] A study performed in Switzerland revealed that the main reasons for non-participation in cervical cancer screening were practical barriers, such as lack of time and the cost of screening.[@R22] The two aforementioned studies and our study support the idea that convenience and accessibility may be major obstacles in achieving a greater degree of cervical cancer screening in the population. In the Norwegian study, higher non-adherence rates were associated with a greater distance to the screening site which is indirectly consistent with our results with regard to living in an urban setting.[@R20] We found being single was associated with a higher likelihood to agree to pap smear screening in the PHC office, though Leinonen *et al* and a study in Lithuania by Petkeviciene *et al*, found being single was associated with non-adherence, suggesting that willingness to undergo screening and later adherence are not necessarily correlated.[@R20]

Implications for practice and screening policy {#s4-4}
----------------------------------------------

There is a need to educate women regarding the importance of cervical cancer screening. The role of FPs as health advocates, as well as a community resource for health education, is essential to reduce the morbidity and mortality from cervical cancer. Our results demonstrate that too many women were neglecting their screening because they had no symptoms. Clearly it is vital that doctors inform patients of the silent nature of cervical cancer, and that the purpose of the screening test is not to confirm a diagnosis, but rather precisely to catch the cancer when it is still asymptomatic. Statements such as these show that patients do not understand the fundamental purpose of the screening test; adherence will not increase if patients are not clear as to the aim of the test. In addition, fears concerning the safety of the test and the need for 'specialised' interventions should adverse events occur also reveal a need for a greater level of patient education. Formal intensive screening for cervical cancer should be launched and supported across Poland. These services if conducted at PHC offices could potentially avoid long wait times and additional scheduling complexity at gynaecological offices.

In order to decrease the mortality of patients with positive cytological testing, there should be a fast track system to gynaecological care in place to expedite medical or surgical treatment. We believe that results from this investigation will streamline the organisation of a pilot study with the goal of studying and introducing more effective cervical cancer screening in the Małopolska region and therefore promote improvements to current Polish PHC.

Conclusion {#s5}
==========

It is crucial to improve the accessibility to cervical cancer screening for patients in Poland. Strategies must be tailored to the needs of the patients; effective approaches should be multifaceted. This requires effective interventions that will concentrate not only on increasing awareness of the importance of prevention and the need for regular pap smears, but also by providing convenient means by which to undergo the test. Taking into the account the high mortality of the cervical cancer in Poland we believe that our study shows possible area of improvement.
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